v3.26.1
Redeemable Convertible Preferred stock - Additional Information (Details)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 17, 2026
USD ($)
$ / shares
shares
Feb. 28, 2026
USD ($)
Mar. 31, 2026
Jun. 30, 2026
$ / shares
shares
Jun. 15, 2026
shares
Jun. 10, 2026
shares
Dec. 31, 2025
$ / shares
shares
Class of Stock [Line Items]              
Preferred stock, shares issued       0     0
Preferred stock, par value | $ / shares       $ 0.0001     $ 0.0001
Common stock, shares authorized       300,000,000   300,000,000 12,500,000
Preferred stock, shares outstanding       0     0
Private Placement              
Class of Stock [Line Items]              
Gross proceeds | $ $ 200.0            
Common Stock              
Class of Stock [Line Items]              
Conversion of preferred stock, shares issued 14,440,395            
Preferred stock convertible conversion price per share | $ / shares $ 13.85            
Faeth Therapeutics LLC | Common Stock              
Class of Stock [Line Items]              
Conversion of preferred stock, shares issued 10,497,098            
Series B Preferred Stock              
Class of Stock [Line Items]              
Preferred stock, shares issued 25,045            
Preferred stock, par value | $ / shares $ 0.0001            
Shares issued 14,440.395            
Share price | $ / shares $ 13,850            
Preferred stock convert to common stock 1,000     1,000      
Description of preferred stock conversion       Each share of Series B Preferred Stock automatically converted at a conversion ratio of 1,000 shares of common stock for each share of Series B Preferred Stock on June 15, 2026, which was the third business day after stockholder approval of the Company Stockholder Matters.      
Preferred stock, voting rights     no        
Preferred stock conversion ratio         0.001    
Series B Preferred Stock | Private Placement              
Class of Stock [Line Items]              
Shares issued 14,440.395            
Series B Preferred Stock | Faeth Therapeutics LLC              
Class of Stock [Line Items]              
Shares issued converted into common stock 10,497.098            
Series B Non-Voting Convertible Preferred Stock              
Class of Stock [Line Items]              
Convertible preferred stock         24,435.594    
Preferred stock, shares outstanding       501.899      
Series B Non-Voting Convertible Preferred Stock | Private Placement              
Class of Stock [Line Items]              
Gross proceeds | $   $ 200.0          
Series B Non-Voting Convertible Preferred Stock | Common Stock              
Class of Stock [Line Items]              
Convertible preferred stock         24,435,594